Skip to main content
. 2011 Mar 24;55(1):e8. doi: 10.4081/ejh.2011.e8

Table 7. Table of contingency (portio vaginalis uteri invasive carcinoma).

Test Disease present (PVU invasive carcinoma) Disease absent (control group) Total
bcl-2 and c-myc co-overexpression 6 (P=0.064) 0 6
bcl-2 and c-myc negative 20 36 56
Total 26 36 62

PVU, portio vaginalis uteri.